Carmel Capital Partners, LLC Merck & Co., Inc. Transaction History
Carmel Capital Partners, LLC
- $234 Million
- Q4 2024
A detailed history of Carmel Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Carmel Capital Partners, LLC holds 3,304 shares of MRK stock, worth $296,567. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,304
Previous 3,411
3.14%
Holding current value
$296,567
Previous $387,000
15.25%
% of portfolio
0.14%
Previous 0.16%
Shares
11 transactions
Others Institutions Holding MRK
# of Institutions
3,972Shares Held
1.86BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.9 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.49 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.97 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $227B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...